DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Lifevantage Corporation (LXRX)
« Back to company indexLXRX Chatter Timeline
Stock Ticker for LXRX
Most Active Tweeters for LXRX
No tweets foundRecent Tweets for LXRX
 |
@registrarjourn Lexicon Pharmaceuticals $LXRX Announces Earnings Results https://t.co/nwiyGg3tei August 22nd 2018, 1:08am |
|
@registrarjourn Lexicon Pharmaceuticals $LXRX Getting Somewhat Positive Media Coverage, Report Shows https://t.co/YklDcjefuR August 21st 2018, 5:08pm |
 |
@EnterpriseLeade Lexicon Pharmaceuticals $LXRX Getting Somewhat Positive Media Coverage, Report Shows https://t.co/vU0453ZwBo August 21st 2018, 5:08pm |
 |
@MareaInformativ Lexicon Pharmaceuticals $LXRX Given Media Sentiment Rating of 0.13 https://t.co/XBAoHgdLdK August 21st 2018, 5:08pm |
|
@registrarjourn BidaskClub Lowers Lexicon Pharmaceuticals $LXRX to Sell https://t.co/aTmyLyqAEi August 21st 2018, 1:08pm |
|
@EnterpriseLeade BidaskClub Lowers Lexicon Pharmaceuticals $LXRX to Sell https://t.co/oUeGsAqgPa August 21st 2018, 1:08pm |
 |
@OlympiaReport Lexicon Pharmaceuticals, Inc. $LXRX Given Average Rating of “Hold” by Analysts https://t.co/GvtvWh8Ql9 August 21st 2018, 8:08am |
 |
@dispatchtribune Lexicon Pharmaceuticals, Inc. $LXRX Given Consensus Rating of “Hold” by Analysts https://t.co/efpWvKfyiy August 21st 2018, 8:08am |
 |
@ThisLincolnian Analysts Expect Lexicon Pharmaceuticals, Inc. $LXRX Will Announce Quarterly Sales of $13.23 Million https://t.co/L1RowXwr6l August 21st 2018, 5:08am |
 |
@WeekHerald Zacks: Brokerages Expect Lexicon Pharmaceuticals, Inc. $LXRX Will Post Quarterly Sales of $13.23 Million https://t.co/MwvVI0u7gZ August 21st 2018, 5:08am |
|
@OlympiaReport Lexicon Pharmaceuticals $LXRX Rating Lowered to Sell at ValuEngine https://t.co/lfo5cSfiqZ August 21st 2018, 5:08am |
|
@MareaInformativ Lexicon Pharmaceuticals $LXRX Downgraded by Zacks Investment Research https://t.co/xe3yTI6xLO August 21st 2018, 5:08am |
|
@WeekHerald Lexicon Pharmaceuticals $LXRX Downgraded by BidaskClub https://t.co/gvbFx5ZDFc August 20th 2018, 10:08am |
|
@dispatchtribune Lexicon Pharmaceuticals $LXRX Cut to Sell at ValuEngine https://t.co/ldYhhZ2STj August 20th 2018, 10:08am |
|
@OlympiaReport Lexicon Pharmaceuticals $LXRX Rating Lowered to Sell at ValuEngine https://t.co/WZJcqc1zPu August 20th 2018, 10:08am |
|
@ThisLincolnian Lexicon Pharmaceuticals $LXRX Downgraded by BidaskClub https://t.co/i5rjWiXEjc August 20th 2018, 10:08am |
 |
@AmericanBanking Analysts Anticipate Lexicon Pharmaceuticals, Inc. $LXRX to Post -$0.32 EPS https://t.co/ev78RjWEGU #stocks August 19th 2018, 8:08pm |
 |
@TranscriptDaily -$0.32 EPS Expected for Lexicon Pharmaceuticals, Inc. $LXRX This Quarter https://t.co/mT9sitQICz August 19th 2018, 8:08pm |
 |
@1MinuteStock We calculated 63-day Expected Return of $LXRX for you: 7.25% https://t.co/U0xohyQX4k August 19th 2018, 7:08pm |
|
@1MinuteStock Wondering about #sentiment indicator for $LXRX? The Short Ratio is 17.25% https://t.co/bT5yJSWwNI August 19th 2018, 7:08pm |
|
@1MinuteStock We calculated 21-day Expected Return of $LXRX for you: -19.76% https://t.co/U0xohyQX4k August 19th 2018, 7:08pm |
 |
@dailypoliticaln Lexicon Pharmaceuticals $LXRX Lowered to Sell at BidaskClub https://t.co/HngnsBEoCQ August 19th 2018, 7:08am |
|
@MareaInformativ Wedbush Comments on Lexicon Pharmaceuticals, Inc.’s Q3 2018 Earnings $LXRX https://t.co/8aMrL1pC7Q August 19th 2018, 2:08am |
 |
@WatchlistN Lexicon Pharmaceuticals $LXRX Downgraded by ValuEngine to “Sell” https://t.co/T8H7HCl5kD August 19th 2018, 2:08am |
 |
@ConsumerFeed Lexicon Pharmaceuticals $LXRX Downgraded to “Sell” at BidaskClub https://t.co/Muru8fbrXc August 18th 2018, 1:08pm |
|
@dailypoliticaln Lexicon Pharmaceuticals $LXRX Lowered to “Sell” at ValuEngine https://t.co/ox6hLRwv8y August 18th 2018, 12:08pm |
 |
@ZolmaxNews Lexicon Pharmaceuticals $LXRX Stock Rating Lowered by ValuEngine https://t.co/91sOUTaMTn August 18th 2018, 12:08pm |
 |
@TickerReport Tyme Technologies $TYME vs. Lexicon Pharmaceuticals $LXRX Head-To-Head Analysis https://t.co/GZKc4bXFCI August 17th 2018, 8:08pm |
|
@dailypoliticaln Lexicon Pharmaceuticals $LXRX vs. Tyme Technologies $TYME Head-To-Head Analysis https://t.co/xxF77d6suY August 17th 2018, 8:08pm |
|
@AmericanBanking Tyme Technologies $TYME vs. Lexicon Pharmaceuticals $LXRX Head-To-Head Analysis https://t.co/CdGaxGZft1 #stocks August 17th 2018, 8:08pm |
 |
@bibeypost_stock Lexicon Pharmaceuticals, Inc. $LXRX has analysts on the Bullish side this week. - https://t.co/mwCSi4cxQ3 August 17th 2018, 3:08pm |
 |
@reurope_stock How Analysts Rated Lexicon Pharmaceuticals, Inc. $LXRX Last Week? https://t.co/1tlqN7XLoQ August 17th 2018, 3:08pm |
 |
@mmahotstuff1 This is what analysts have to say about Lexicon Pharmaceuticals, Inc. $LXRX after last week. - https://t.co/k6ZFJSA8ZL August 17th 2018, 3:08pm |
 |
@whatsonthorold2 Are Analysts Bullish Lexicon Pharmaceuticals, Inc. $LXRX After Last Week? - https://t.co/86OQiVWEZR August 17th 2018, 3:08pm |
 |
@west_moreland Discussion stirs around Lexicon Pharmaceuticals, Inc. $LXRX this week; here is what analysts are saying. https://t.co/iFO1fqFKeA August 17th 2018, 2:08pm |
 |
@Fanob_stock Were Analysts Bullish Lexicon Pharmaceuticals, Inc. $LXRX This Week? https://t.co/BqTdFLgUga August 17th 2018, 2:08pm |
|
@WatchlistN Lexicon Pharmaceuticals $LXRX Downgraded to Sell at BidaskClub https://t.co/F3zgZ0bqsx August 17th 2018, 6:08am |
|
@TickerReport Lexicon Pharmaceuticals $LXRX Downgraded to Sell at BidaskClub https://t.co/M9bDSrpdu1 August 17th 2018, 6:08am |
|
@ConsumerFeed Lexicon Pharmaceuticals $LXRX Cut to Sell at ValuEngine https://t.co/lBUKZ4DfwG August 17th 2018, 1:08am |
|
@MareaInformativ Lexicon Pharmaceuticals $LXRX Receives News Sentiment Score of 0.13 https://t.co/CqSBIV7lEz August 16th 2018, 12:08pm |
|
@EnterpriseLeade Lexicon Pharmaceuticals $LXRX Lowered to Hold at BidaskClub https://t.co/IZ9VRencrW August 16th 2018, 8:08am |
 |
@usindexlive Dorsey Wright & Associates Has Lifted Its Grupo Financiero Galicia S Asp $GGAL Stake; Lexicon Pharmaceuticals $LXRX… https://t.co/IDMEV7udQ3 August 16th 2018, 8:08am |
|
@TickerReport Recent Analysts’ Ratings Updates for Lexicon Pharmaceuticals $LXRX https://t.co/vrdUs0r69L August 16th 2018, 2:08am |
|
@dailypoliticaln Recent Analysts’ Ratings Updates for Lexicon Pharmaceuticals $LXRX https://t.co/Gqb4lsUffl August 16th 2018, 2:08am |
|
@AmericanBanking Recent Analysts’ Ratings Updates for Lexicon Pharmaceuticals $LXRX https://t.co/ohFg5IZnbE #stocks August 16th 2018, 2:08am |
 |
@dogwhistles $LXRX down nearly 4% atm. Had to get out the door early this morning so did not have a chance to watch things pre-market over coffees ???? August 15th 2018, 1:08pm |
|
@registrarjourn Stifel Nicolaus Reaffirms Buy Rating for Lexicon Pharmaceuticals $LXRX https://t.co/KD1j9bplvl August 15th 2018, 12:08am |
|
@EnterpriseLeade Stifel Nicolaus Reaffirms Buy Rating for Lexicon Pharmaceuticals $LXRX https://t.co/t6ZIswhxjW August 15th 2018, 12:08am |
|
@EnterpriseLeade Lexicon Pharmaceuticals $LXRX Issues Earnings Results https://t.co/MJYC2wFHU9 August 14th 2018, 3:08am |
|
@dogwhistles $LXRX back to 9.13/11.44. That no longer interests me. Back to $ACBFF ? August 13th 2018, 9:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.